REX American Resources (REX) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for June 4, 2025, with multiple voting options including online, mail, and in-person participation.
Proxy materials are available online, and shareholders are encouraged to enroll in e-Consent for paperless access.
Voting matters and shareholder proposals
Shareholders will vote on the election of eight director nominees.
Advisory vote on executive compensation is included on the agenda.
Ratification of the appointment of the independent registered public accounting firm is up for vote.
Proxies may vote on other business that may properly come before the meeting.
Board of directors and corporate governance
Board recommends voting "FOR" all director nominees and all other proposals.
Director nominees include Stuart A. Rose, Zafar A. Rizvi, Edward M. Kress, David S. Harris, Charles A. Elcan, Mervyn L. Alphonso, Lee I. Fisher, Anne C. MacMillan, and Cheryl L. Bustos.
Latest events from REX American Resources
- Net income up 37% to $12.4M, with strong cash and on-track expansion despite revenue drop.REX
Q2 202523 Jan 2026 - Second most profitable quarter, strong cash, and project progress despite regulatory delays.REX
Q3 202512 Jan 2026 - FY24 profit fell on lower ethanol prices, but margin, cash, and buybacks strengthened.REX
Q4 202526 Dec 2025 - Q3 2025 saw steady sales, $0.71 EPS, and major expansion and carbon capture progress.REX
Q3 20267 Dec 2025 - Q3 2025 saw strong sales, ongoing expansion, and major progress in carbon capture initiatives.REX
Investor Presentation4 Dec 2025 - Proxy covers director elections, executive pay, auditor ratification, and board governance.REX
Proxy Filing1 Dec 2025 - Revenue up 7%, net income down 43%; expansion, stock split, and strong cash position advance.REX
Q2 202623 Nov 2025 - Q1 2025 profit streak continues with $8.7M net income, strong cash, and major project investments.REX
Q1 202621 Nov 2025 - Q2 2025 saw strong sales, ongoing CCS expansion, and robust financial health with no bank debt.REX
Investor Presentation27 Aug 2025